Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05798663
Title Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Alliance Foundation Trials, LLC.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Missouri Baptist Medical Center RECRUITING Saint Louis Missouri 63131 United States Details
New Hampshire Oncology - Hematology, PA RECRUITING Manchester New Hampshire 03103 United States Details
Hematology Oncology Associates of Central New York, P.C. RECRUITING East Syracuse New York 13057 United States Details
SUNY Upstate Medical University RECRUITING Syracuse New York 13210 United States Details
Ohio State University RECRUITING Columbus Ohio 43210 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field